Survival Statistics for Bone Cancer

Survival rates are often used by doctors as a standard way of discussing a person’s prognosis (outlook). Some people with cancer may want to know the survival statistics for people in similar situations, while others may not find the numbers helpful, or may even not want to know them.

The 5-year survival rate refers to the percentage of patients who live at least 5 years after their cancer is diagnosed. Of course, many people live much longer than 5 years (and many are cured).

Five-year relative survival rates assume that some people will die of other causes and compare the observed survival with that expected for people without the cancer. This is a better way to see the impact of the cancer on survival.

To get 5-year survival rates, doctors have to look at people who were treated at least 5 years ago. Improvements in treatment since then may result in a more favorable outlook for people diagnosed with bone cancer today.

Survival rates are often based on previous outcomes of large numbers of people who had the disease, but they cannot predict what will happen in any particular person’s case. Many factors may affect a person’s outlook, such as the type and grade of the cancer, the patient’s age, where the cancer is located, the size of the tumor, and the treatment received. Your doctor can tell you how the numbers below may apply to you, as he or she is familiar with the aspects of your situation.

For all cases of bone cancer combined (in both adults and children), the 5-year relative survival is about 70%. For adults, the most common bone cancer is chondrosarcoma, which has a 5-year relative survival of about 80%. (Survival statistics for Ewing tumors and osteosarcoma can be found in our information about those cancers.)

The American Cancer Society medical and editorial content team
Our team is made up of doctors and master's-prepared nurses with deep knowledge of cancer care as well as journalists, editors, and translators with extensive experience in medical writing.

Last Medical Review: November 28, 2017 Last Revised: February 5, 2018

American Cancer Society medical information is copyrighted material. For reprint requests, please see our Content Usage Policy.